The adaptive immune response in AD is associated with the increased expression of the Th2 cytokines (IL-4, IL-5, IL-13, and IL-31) and the Th22 cytokine IL-22 during the acute phase of AD [54,55]. This evidence concerns the gene IL22 and Alzheimer disease.